Prime Medicine, Inc. Share-based Payment Arrangement, Expense in USD from 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Prime Medicine, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to Q3 2025.
  • Prime Medicine, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $12.7M, a 86.7% increase year-over-year.
  • Prime Medicine, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $30.7M, a 25% increase year-over-year.
  • Prime Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $26.1M, a 87.4% increase from 2023.
  • Prime Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $13.9M, a 115% increase from 2022.
  • Prime Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.46M, a 270% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Prime Medicine, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $30.7M $12.7M +$5.92M +86.7% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-07
Q2 2025 $24.8M $6.33M -$1.77M -21.8% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $26.5M $5.68M +$472K +9.06% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $26.1M $5.94M +$1.51M +34.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-28
Q3 2024 $24.6M $6.83M +$2.61M +61.9% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-07
Q2 2024 $21.9M $8.09M +$4.51M +126% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $17.4M $5.21M +$3.53M +210% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $13.9M $4.43M +$1.86M +72.1% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-28
Q3 2023 $12.1M $4.22M +$2.8M +198% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $9.26M $3.58M +$2.24M +166% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $7.02M $1.68M +$558K +49.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $6.46M $2.57M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 $1.42M +$1.08M +318% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $1.35M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $1.12M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $339K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14

Prime Medicine, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $26.1M +$12.2M +87.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-28
2023 $13.9M +$7.45M +115% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-28
2022 $6.46M +$4.71M +270% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 $1.75M +$1.36M +347% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $391K Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.